Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster.
View Publication On PubMed
Export 
BiBTeXSEEK ID: https://ldh.uk-wuerzburg.imise.uni-leipzig.de/publications/6
PubMed ID: 36657489
Trial Projects: CoVacSer
Publication type: Journal
Journal: Clin Microbiol Infect
Citation: Clin Microbiol Infect. 2023 Apr;29(4):554-556. doi: 10.1016/j.cmi.2023.01.008. Epub 2023 Jan 16.
Date Published: 4th Apr 2023
Registered Mode: by PubMed ID
Export PNG
Download
Submitter
Views: 66
Created: 31st Oct 2024 at 13:56
TagsThis item has not yet been tagged.
AttributionsNone
Related items
https://orcid.org/0009-0000-4383-3107
Josef-Schneider-Straße 2, 97080, Würzburg, Germany
ROR-ID: 03pvr2g57
Trial Projects:
- CoVacSer
- WüRDT
- ARIPro
- Vaccination status and use of complementary medicine in patients with primary immunodeficiency
- Ralstonia pickettii
- Semi-automated infection surveillance in obstetrics and gynecology
Web page: https://www.ukw.de/
The prospective CoVacSer cohort study examines SARS-CoV-2 immunity derived from serial blood samples as well as survey-based quality of life and ability to work in HCWs after COVID-19 vaccination and/or SARS-CoV-2 infection.
Sponsor: University Hospital Würzburg
Public web page: Not specified
Start date: 29th Sep 2021
End date: 31st Dec 2023
